Annual report pursuant to Section 13 and 15(d)

Investments (Schedule of Equity Method Investment) (Details)

v3.24.0.1
Investments (Schedule of Equity Method Investment) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
 Balance Sheets      
Current assets $ 263,808 $ 311,291  
Current liabilities 292,534 327,064  
 Statements of Operations      
Loss from operations (204,481) (66,024) $ 40,541
Net loss (245,774) (85,480) 12,694
Envestnet’s proportional share of gains (losses) (238,724) (80,939) 13,296
Equity Method Investments, Total      
 Balance Sheets      
Current assets 68,602 42,059  
Other assets 66,016 50,703  
Current liabilities 17,150 17,647  
Other liabilities 1,857 9,437  
 Statements of Operations      
Revenue 71,815 79,062 65,085
Loss from operations (16,733) (8,896) (149)
Net loss (20,235) (7,124) (134)
Envestnet’s proportional share of gains (losses) (10,033) 643 $ (7,093)
Dilution gain on equity method investee share issuance $ 500 $ 9,500